my account
log out
|
|
my account
log out
|
Afuco™ Anti-HIV gp41 ADCC Theraputic Antibody, ADCC Enhanced |
| Create: 08/09/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-HIV gp41 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-HIV-1 gp41 antibodies are used for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection. https://www.creativebiolabs.net/Anti-HIV-gp41-ADCC-Enhanced-Antibody-20647.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 233 | |
| Feb 01 2023 | GVBE Buffer | 234 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 240 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 228 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 421 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 503 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 413 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 429 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 410 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 438 |
| Copyright © toextrade Inc. All rights reserved. Contact us |